Target intelligence / Profile preview

Reactive oxygen species and electrophilic free radicals (ROS)

Target
ROS
Molecular classification
Other
01

Overview

Reactive oxygen species (ROS) and electrophilic free radicals are highly reactive chemical entities, including superoxide, hydroxyl radicals, and hydrogen peroxide, that are generated during normal cellular metabolism (StatPearls, 2023). At physiological levels, they function as secondary messengers in signal transduction pathways and are essential for the immune system's ability to kill pathogens (PubMed, 2021). However, excessive production or impaired clearance leads to oxidative stress, which causes significant damage to cellular macromolecules such as DNA, lipids, and proteins (NIH, 2022). This damage is a key driver in the progression of various diseases, including cancer, atherosclerosis, and neurodegenerative conditions like Alzheimer's and Parkinson's disease (Nature Reviews, 2020). Therapeutic approaches targeting these species involve the administration of antioxidants and radical scavengers, such as edaravone or N-acetylcysteine, which directly react with and neutralize the radicals to prevent tissue injury (FDA, 2017).

Other names
Free radicalsOxidantsReactive oxygen speciesElectrophilic speciesPro-oxidantsOxygen radicals
02

Mechanism of action

Direct chemical scavenging and neutralization of reactive oxygen species and free radicals to prevent oxidative damage to cellular components.

03

Biological functions

Signal transductionApoptosisImmune responseCell deathHomeostasis
04

Disease associations

CancerInflammationNeurodegenerative diseaseCardiovascular diseaseDiabetesAging
05

Safety considerations

Interference with essential redox signaling pathwaysPotential pro-oxidant activity at high concentrationsDisruption of physiological immune responses (oxidative burst)Poor clinical translation of non-specific antioxidants
06

Interacting drugs

Edaravone

6 more in the full profile.

07

Biomarkers

8-hydroxy-2'-deoxyguanosine (8-OHdG)Malondialdehyde (MDA)IsoprostanesProtein carbonylsGlutathione disulfide (GSSG) to Glutathione (GSH) ratio

Beyond the preview

Go deeper on Reactive oxygen species and electrophilic free radicals (ROS).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Reactive oxygen species and electrophilic free radicals (ROS).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call